Target-Controlled Infusion: A Mature Technology

Target-controlled infusions (TCIs) have been used in research and clinical practice for >2 decades. Nonapproved TCI software systems have been used during the conduct of almost 600 peer-reviewed published studies involving large numbers of patients. The first-generation pumps were first approved in 1996, and since then an estimated 25,000 units have been sold and used. Second-generation pumps were first approved in 2003. During 2004 to 2013, >36,000 units were sold. Currently, TCI systems are approved or available in at least 96 countries. TCI systems are used to administer propofol and opioids for IV sedation and general anesthesia for millions of patients every year. In countries where TCI systems are approved, nonapproved software is still commonly used in studies of the pharmacology of hypnotics and opioids, because research software offers greater flexibility than approved TCI systems. Research software is also readily integrated into data management modules. Although TCI is a part of established practice around the world, TCI devices have not received regulatory approval in the United States. In the United States, TCI administration of propofol and opioids for sedation and anesthesia is only possible using research software in IRB-approved research studies.

[1]  S L Shafer,et al.  The influence of age on propofol pharmacodynamics. , 1999, Anesthesiology.

[2]  M. Struys,et al.  An assessment of computer-assisted personalized sedation: a sedation delivery system to administer propofol for gastrointestinal endoscopy. , 2006, Gastrointestinal endoscopy.

[3]  Laurent Beydon,et al.  Closed-Loop Coadministration of Propofol and Remifentanil Guided by Bispectral Index: A Randomized Multicenter Study , 2011, Anesthesia and analgesia.

[4]  M. White,et al.  Accuracy of the 'Paedfusor' in children undergoing cardiac surgery or catheterization. , 2003, British journal of anaesthesia.

[5]  D R Stanski,et al.  Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. , 1987, The Journal of pharmacology and experimental therapeutics.

[6]  S L Shafer,et al.  Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil: I. Model Development , 1997, Anesthesiology.

[7]  J. Vargo,et al.  Computer-assisted personalized sedation for upper endoscopy and colonoscopy: a comparative, multicenter randomized study. , 2011, Gastrointestinal endoscopy.

[8]  S L Shafer,et al.  Nomenclature for computer-assisted infusion devices. , 1997, Anesthesiology.

[9]  N. Morton,et al.  Pharmacokinetic model driven infusion of propofol in children. , 1991, British journal of anaesthesia.

[10]  D. Stanski,et al.  Linearity of Pharmacokinetics and Model Estimation of Sufentanil , 1995, Anesthesiology.

[11]  K. Leslie,et al.  Target-Controlled Infusion Versus Manually-Controlled Infusion of Propofol for General Anaesthesia or Sedation in Adults , 2008, Anesthesia and analgesia.

[12]  T. Cook,et al.  The state of UK anaesthesia: a survey of National Health Service activity in 2013. , 2014, British journal of anaesthesia.

[13]  Michel M. R. F. Struys,et al.  A General Purpose Pharmacokinetic Model for Propofol , 2014, Anesthesia and analgesia.

[14]  Thomas W. Schnider,et al.  Pharmacokinetics and Pharmacodynamics of Remifentanil , 1997 .

[15]  Laurent Beydon,et al.  Automated titration of propofol and remifentanil decreases the anesthesiologist’s workload during vascular or thoracic surgery: a randomized prospective study , 2014, Journal of Clinical Monitoring and Computing.

[16]  S. Shafer,et al.  The Influence of Method of Administration and Covariates on the Pharmacokinetics of Propofol in Adult Volunteers , 1998, Anesthesiology.

[17]  Thomas W. Schnider,et al.  The History of Target-Controlled Infusion , 2016, Anesthesia and analgesia.

[18]  D R Stanski,et al.  Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients. , 1987, Anesthesiology.

[19]  James C. Scott,et al.  Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. , 1990, Anesthesiology.

[20]  B L Ehrenberg,et al.  Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo , 1989, Clinical pharmacology and therapy.

[21]  D. Eleveld,et al.  Performance of Propofol Target-Controlled Infusion Models in the Obese: Pharmacokinetic and Pharmacodynamic Analysis , 2014, Anesthesia and analgesia.

[22]  Reaction time‐monitored patient‐maintained propofol sedation: a pilot study in oral surgery patients , 2013, Anaesthesia.

[23]  S L Shafer,et al.  Pharmacokinetics and Pharmacodynamics of Remifentanil: II. Model Application , 1997, Anesthesiology.

[24]  H F Nicodemus,et al.  The Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches , 1994, Anesthesiology.

[25]  J. Rouby,et al.  Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial , 2013, Intensive Care Medicine.

[26]  Effectiveness, safety, and pharmacokinetic and pharmacodynamic characteristics of microemulsion propofol in patients undergoing elective surgery under total intravenous anaesthesia. , 2010, British journal of anaesthesia.

[27]  G. Kenny,et al.  'Paedfusor' pharmacokinetic data set. , 2005, British journal of anaesthesia.

[28]  H. Schwilden,et al.  A general method for calculating the dosage scheme in linear pharmacokinetics , 2004, European Journal of Clinical Pharmacology.